We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
+9.39%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$24.4B
AUM Growth
+$3.12B
(+15%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
4.34%
Top 10 Holdings %
Top 10 Hldgs %
37.26%
Holding
101
New
20
Increased
28
Reduced
27
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$1.02B |
| 2 |
Philip Morris
PM
|
+$865M |
| 3 |
Workday
WDAY
|
+$480M |
| 4 |
Everest Group
EG
|
+$375M |
| 5 |
CBRE Group
CBRE
|
+$343M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$1.03B |
| 2 |
Chubb
CB
|
+$489M |
| 3 |
Amazon
AMZN
|
+$368M |
| 4 |
Elevance Health
ELV
|
+$342M |
| 5 |
CSX Corp
CSX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.11% |
| 2 | Technology | 20.13% |
| 3 | Financials | 16.96% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
76
DELISTED
Day One Biopharmaceuticals
DAWN
| $30.5M | 0.13% |
2,558,563
+1,000,000
| +64% | +$13.1M |
|
77
Tenet Healthcare
THC
$20.9B
| $29.6M | 0.12% |
+363,800
| New | +$25.9M |
|
|
FTCH
78
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $28.8M | 0.12% |
4,769,602
-2,333,855
| -33% | -$11.2M |
|
79
Rallybio
RLYB
$87M
| $23.7M | 0.1% |
524,347
| – | – |
|
80
Verastem
VSTM
$638M
| $14M | 0.06% |
1,886,292
+1,117,625
| +145% | +$7.76M |
|
81
PepGen
PEPG
$201M
| $13.3M | 0.05% |
1,482,434
-62,197
| -4% | -$813K |
|
82
Trevi Therapeutics
TRVI
$2.54B
| $10.5M | 0.04% |
4,400,000
| – | – |
|
|
LIAN
83
DELISTED
LianBio American Depositary Shares
LIAN
| $8.13M | 0.03% |
3,564,173
| – | – |
|
84
C3.ai
AI
$1.65B
| $6.54M | 0.03% |
+179,653
| New | +$5.06M |
|
|
KNTE
85
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.52M | 0.02% |
1,820,462
| – | – |
|
86
Boston Scientific
BSX
$74.2B
| – | – |
-1,136,881
| Closed | -$56.9M |
|
87
Charles River Laboratories
CRL
$13.5B
| – | – |
-394,089
| Closed | -$79.5M |
|
88
Equitable Holdings
EQH
$14B
| – | – |
-3,989,446
| Closed | -$101M |
|
89
Inspire Medical Systems
INSP
$1.71B
| – | – |
-346,576
| Closed | -$81.1M |
|
|
MRSH
90
Marsh
MRSH
$91.3B
| – | – |
-257,443
| Closed | -$42.9M |
|
91
Molina Healthcare
MOH
$10.2B
| – | – |
-594,553
| Closed | -$159M |
|
92
Intellia Therapeutics
NTLA
$1.68B
| – | – |
-1,569,545
| Closed | -$58.5M |
|
93
Option Care Health
OPCH
$3.61B
| – | – |
-1,090,497
| Closed | -$34.6M |
|
94
Snowflake
SNOW
$116B
| – | – |
-382,757
| Closed | -$59.1M |
|
95
TJX Companies
TJX
$172B
| – | – |
-414,401
| Closed | -$32.5M |
|
|
TRML
96
DELISTED
Tourmaline Bio
TRML
| – | – |
-328,962
| Closed | -$6.18M |
|
97
Travelers Companies
TRV
$78.3B
| – | – |
-378,345
| Closed | -$64.9M |
|
|
XYZ
98
Block Inc
XYZ
$47.5B
| – | – |
-2,354,123
| Closed | -$162M |
|
|
CTLT
99
DELISTED
CATALENT, INC.
CTLT
| – | – |
-1,201,210
| Closed | -$78.9M |
|
|
FRC
100
DELISTED
First Republic Bank
FRC
| – | – |
-276,260
| Closed | -$3.86M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2023 Portfolio in Review
As of Q2 2023, Viking Global Investors held 101 positions worth $24.4B, up 15% from $21.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Viking Global Investors deployed $1.06B of net new capital in Q2 2023, opening 20 new positions and adding to 28 existing holdings. Its largest new stake was Danaher: 4,801,626 shares worth $1.02B.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 36% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was McKesson, an estimated $1.03B trimmed.
- Viking Global Investors's largest Q2 2023 buy was Danaher: 4,801,626 shares worth $1.02B.
- Viking Global Investors added most to Workday in Q2 2023, an estimated $480M increase.
- Viking Global Investors's biggest Q2 2023 reduction was McKesson, cutting an estimated $1.03B.
- Viking Global Investors fully exited Block Inc in Q2 2023, selling an estimated $162M.
- Viking Global Investors's ten largest holdings make up 37% of its $24.4B portfolio in Q2 2023.
- Viking Global Investors opened 20 new positions and closed 15 in Q2 2023.
- Viking Global Investors's portfolio value rose 15% quarter-over-quarter to $24.4B.
Based on Viking Global Investors's 13F filing for Q2 2023, filed 14 Aug 2023.